Bortezomib, Paclitaxel, and Carboplatin as a First-Line Regimen for Patients with Metastatic Esophageal, Gastric, and Gastroesophageal Cancer: Phase II Results from the North Central Cancer Treatment Group (N044B)1
- Citation:
- J Thorac Oncol vol 3 (5) 516-520
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10 CA035267, U10 CA037417, N01 CA035431, U10 CA035269, CA-37404, CA-35090, U10 CA060276, CA-35195, U10 CA037404, N01 CA035119, U10 CA063848, U10 CA035195, CA-35103, CA-25224, CA-60276, CA-35113, U10 CA035113, P30 CA015083, CA-52654, CA-63848, U10 CA063849, U10 CA035431, U10 CA035119, CA-37417, CA-35269, U10 CA052654, U10 CA025224, U10 CA035090, CA-15083, CA-35267, CA-63849, N01 CA015083, U10 CA035103
- Corr. Author:
- Authors:
- Aminah Jatoi Shaker R. Dakhil Nathan R. Foster Cynthia Ma Kendrith M. Rowland Dennis F. Moore Anthony J. Jaslowski Sachdev P. Thomas Mark D. Hauge Patrick J. Flynn Philip J. Stella Steven R. Alberts
- Networks:
- Study
- NCCTG-N044B
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Article